Logo image of DBTX

DECIBEL THERAPEUTICS INC (DBTX) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:DBTX - US24343R1068 - Common Stock

4.91 USD
-0.04 (-0.81%)
Last: 9/22/2023, 8:00:01 PM
4.91 USD
0 (0%)
After Hours: 9/22/2023, 8:00:01 PM
Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to DBTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.78. This target is 58.4% above the current price.
DBTX was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about DBTX.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
DBTX was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

DBTX Historical Analyst RatingsDBTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -29 -26 -23 -20 -17 -14 -11 -8 -5 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 4.915.307.787.7810.50 - 7.99% 58.40% 58.40% 113.85%

Related screens

DBTX Current Analyst RatingDBTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2023-08-10 Baird Downgrade Outperform -> Neutral
2023-08-09 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-06-06 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-15 SVB Leerink Downgrade Outperform -> Market Perform
2023-03-15 HC Wainwright & Co. Reiterate Buy
2023-02-13 HC Wainwright & Co. Reiterate Buy
2023-01-23 SVB Leerink Maintains Outperform
2022-11-10 Citigroup Maintains Buy
2022-05-17 Citigroup Maintains Buy
2021-12-02 JonesTrading Initiate Buy
2021-11-15 HC Wainwright & Co. Initiate Buy
2021-11-10 SVB Leerink Maintains Outperform
2021-10-22 Baird Initiate Outperform
2021-05-14 SVB Leerink Maintains Outperform
2021-03-09 BMO Capital Initiate Outperform
2021-03-09 SVB Leerink Initiate Outperform
2021-03-09 Barclays Initiate Overweight
2021-03-09 Citigroup Initiate Buy

DECIBEL THERAPEUTICS INC / DBTX FAQ

What do analysts expect the price target to be for DECIBEL THERAPEUTICS INC (DBTX)?

10 analysts have analysed DBTX and the average price target is 7.78 USD. This implies a price increase of 58.4% is expected in the next year compared to the current price of 4.91.


How do analysts rate DECIBEL THERAPEUTICS INC (DBTX)?

The consensus rating for DECIBEL THERAPEUTICS INC (DBTX) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for DBTX stock?

The number of analysts covering DECIBEL THERAPEUTICS INC (DBTX) is 10.